Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.

Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry

Abstract

The liver is critical to consider during drug development because of its central role in the handling of xenobiotics, a process which often leads to localized and/or downstream tissue injury. Our ability to predict human clinical safety outcomes with animal testing is limited due to species differences in drug metabolism and disposition, while traditional human in vitro liver models often lack the necessary in vivo physiological fidelity. To address this, increasing numbers of liver microphysiological systems (MPS) are being developed, however the inconsistency in their optimization and characterization often leads to models that do not possess critical levels of baseline performance that is required for many pharmaceutical industry applications. Herein we provide a guidance on best approaches to benchmark liver MPS based on 3 stages of characterization that includes key performance metrics and a 20 compound safety test set. Additionally, we give an overview of frequently used liver injury safety assays, describe the ideal MPS model, and provide a perspective on currently best suited MPS contexts of use. This pharmaceutical industry guidance has been written to help MPS developers and end users identify what could be the most valuable models for safety risk assessment.

Overview

Integrity signals

Registry

Crossref · 10.1039/c9lc00768g

Cites

94 of 94 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 15

  1. R. Becker , A.Chakravarty , D.Cho , O.Faris , S.Fitzpatrick , N.Hunter , I.Irony , S.Lababidi , C.Leptak , W.Mattes , E.Mishina , K.O'Callaghan , M.Pacanowski , E.Papadopoulos , V.Peiris , R.Puri , M.Robb , H.Rogers , R.Sherman , R.Sridhara , R.Temple , A.Trentacosti , P.Turfle , S.Wang , H.Hamilton , P.McInnes , L.McShane and M.Shah , BEST (Biomarkers, EndpointS, and other Tools) Resource , Silver Spring (MD) , 2018
  2. Kizawa, 2017, Biochem. Biophys. Rep., 10, 186
  3. Chen, 2013, Hepatology, 58, 388, 10.1002/hep.26208 · DOI · Paper page
  4. Hosey, 2016, AAPS J., 18, 251, 10.1208/s12248-015-9845-2 · DOI
  5. Shah, 2015, Toxicol. Sci., 147, 500, 10.1093/toxsci/kfv152 · DOI · Paper page
  6. Kock, 2014, Drug Metab. Dispos., 42, 665, 10.1124/dmd.113.054304 · DOI · Paper page
  7. Morgan, 2010, Toxicol. Sci., 118, 485, 10.1093/toxsci/kfq269 · DOI · Paper page
  8. Aleo, 2014, Hepatology, 60, 1015, 10.1002/hep.27206 · DOI · Paper page
  9. Proctor, 2017, Arch. Toxicol., 91, 2849, 10.1007/s00204-017-2002-1 · DOI · Paper page
  10. Bell, 2016, Sci. Rep., 6, 25187, 10.1038/srep25187 · DOI · Paper page
  11. Ballmer, 1990, Am. J. Physiol., 259, E797
  12. Hovens, 1994, Ned. Tijdschr. Geneeskd., 138, 363
  13. Prior, 2003, J. Psychiatry Neurosci., 28, 99
  14. Kostrubsky, 2000, Drug Metab. Dispos., 28, 1192
  15. Stork, 1997, J. Toxicol., 35, 105

Cited by

See all 151

Metadata

Authors
Baudy, A. R., Otieno, M. A., Hewitt, P., Gan, J., Roth, A., Keller, D., Sura, R., Van Vleet, T. R., & Proctor, W. R.
Affiliations
  • Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
  • Springhouse (US)
  • Merck KGaA, Darmstadt (Germany) (DE)
  • Bristol-Myers Squibb (United States) (US)
  • F. Hoffmann-La Roche AG (CH)
  • Sanofi (United States) (US)
  • AbbVie (United States) (US)
  • AbbVie, Inc.
  • Genentech (US)
Corresponding author
Baudy, Andreas R.
Venue
Lab on a Chip
Published
2020
Volume
20
Issue
2
Pages
215-225
ISSN
  • 1473-0189 (ISSN-L)
  • 1473-0197
OpenAlex
W2990102938
Cited by
150
References
94
Citations by year
2026: 22 · 2025: 27 · 2024: 22 · 2023: 20 · 2022: 23 · 2021: 27 · 2020: 9
FWCI
1.19
Type
journal article
Language
en
Open access
closed
Locations
  • Lab on a Chip (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
Keywords
liver-on-a-chip, liver injury, hepatotoxicity, model characterization, model benchmarking, key performance indicators, in vitro liver models, drug metabolism, species differences in drug metabolism, drug development
MeSH terms
Animals, Drug Industry, Drug Evaluation, Preclinical, Pharmaceutical Preparations, Humans, Liver, Risk Assessment, Lab-On-A-Chip Devices

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.